nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—ATP4A—coronary artery disease	0.366	0.803	CbGaD
Esomeprazole—CYP2C19—coronary artery disease	0.09	0.198	CbGaD
Esomeprazole—CYP2C19—Gemfibrozil—coronary artery disease	0.0285	0.0918	CbGbCtD
Esomeprazole—CYP2C19—Clopidogrel—coronary artery disease	0.0247	0.0796	CbGbCtD
Esomeprazole—CYP2C19—Telmisartan—coronary artery disease	0.0216	0.0696	CbGbCtD
Esomeprazole—CYP3A4—Ticagrelor—coronary artery disease	0.0193	0.0623	CbGbCtD
Esomeprazole—CYP2C19—Timolol—coronary artery disease	0.0174	0.0561	CbGbCtD
Esomeprazole—CYP3A4—Fenofibrate—coronary artery disease	0.0172	0.0555	CbGbCtD
Esomeprazole—CYP2C19—Rosuvastatin—coronary artery disease	0.0159	0.0513	CbGbCtD
Esomeprazole—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.0155	0.05	CbGbCtD
Esomeprazole—CYP2C19—Simvastatin—coronary artery disease	0.0148	0.0477	CbGbCtD
Esomeprazole—CYP2C19—Lovastatin—coronary artery disease	0.0145	0.0467	CbGbCtD
Esomeprazole—CYP3A4—Gemfibrozil—coronary artery disease	0.0138	0.0444	CbGbCtD
Esomeprazole—CYP2C19—Atorvastatin—coronary artery disease	0.0132	0.0425	CbGbCtD
Esomeprazole—CYP2C19—Losartan—coronary artery disease	0.0121	0.0389	CbGbCtD
Esomeprazole—CYP3A4—Clopidogrel—coronary artery disease	0.0119	0.0385	CbGbCtD
Esomeprazole—CYP3A4—Eplerenone—coronary artery disease	0.0111	0.0358	CbGbCtD
Esomeprazole—CYP3A4—Enalapril—coronary artery disease	0.0099	0.0319	CbGbCtD
Esomeprazole—CYP3A4—Ezetimibe—coronary artery disease	0.0077	0.0248	CbGbCtD
Esomeprazole—CYP3A4—Rosuvastatin—coronary artery disease	0.0077	0.0248	CbGbCtD
Esomeprazole—CYP3A4—Simvastatin—coronary artery disease	0.00716	0.0231	CbGbCtD
Esomeprazole—CYP3A4—Lovastatin—coronary artery disease	0.007	0.0226	CbGbCtD
Esomeprazole—CYP3A4—Pravastatin—coronary artery disease	0.007	0.0226	CbGbCtD
Esomeprazole—CYP3A4—Atorvastatin—coronary artery disease	0.00638	0.0205	CbGbCtD
Esomeprazole—CYP3A4—Losartan—coronary artery disease	0.00583	0.0188	CbGbCtD
Esomeprazole—Rabeprazole—ATP4A—coronary artery disease	0.000879	0.225	CrCbGaD
Esomeprazole—Pantoprazole—ATP4A—coronary artery disease	0.000879	0.225	CrCbGaD
Esomeprazole—Omeprazole—ATP4A—coronary artery disease	0.000717	0.184	CrCbGaD
Esomeprazole—Lansoprazole—ATP4A—coronary artery disease	0.000656	0.168	CrCbGaD
Esomeprazole—Rabeprazole—CYP2C19—coronary artery disease	0.000216	0.0555	CrCbGaD
Esomeprazole—Pantoprazole—CYP2C19—coronary artery disease	0.000216	0.0555	CrCbGaD
Esomeprazole—Omeprazole—CYP2C19—coronary artery disease	0.000176	0.0452	CrCbGaD
Esomeprazole—Lansoprazole—CYP2C19—coronary artery disease	0.000161	0.0413	CrCbGaD
Esomeprazole—Dizziness—Simvastatin—coronary artery disease	3.19e-05	0.000179	CcSEcCtD
Esomeprazole—Rash—Ezetimibe—coronary artery disease	3.19e-05	0.000179	CcSEcCtD
Esomeprazole—Dermatitis—Ezetimibe—coronary artery disease	3.19e-05	0.000179	CcSEcCtD
Esomeprazole—Confusional state—Ramipril—coronary artery disease	3.19e-05	0.000179	CcSEcCtD
Esomeprazole—Discomfort—Timolol—coronary artery disease	3.19e-05	0.000178	CcSEcCtD
Esomeprazole—Asthenia—Niacin—coronary artery disease	3.18e-05	0.000178	CcSEcCtD
Esomeprazole—Fatigue—Losartan—coronary artery disease	3.18e-05	0.000178	CcSEcCtD
Esomeprazole—Headache—Ezetimibe—coronary artery disease	3.17e-05	0.000178	CcSEcCtD
Esomeprazole—Malaise—Lisinopril—coronary artery disease	3.17e-05	0.000177	CcSEcCtD
Esomeprazole—Anaphylactic shock—Ramipril—coronary artery disease	3.16e-05	0.000177	CcSEcCtD
Esomeprazole—Vertigo—Lisinopril—coronary artery disease	3.16e-05	0.000177	CcSEcCtD
Esomeprazole—Dry mouth—Timolol—coronary artery disease	3.16e-05	0.000177	CcSEcCtD
Esomeprazole—Pain—Losartan—coronary artery disease	3.16e-05	0.000177	CcSEcCtD
Esomeprazole—Constipation—Losartan—coronary artery disease	3.16e-05	0.000177	CcSEcCtD
Esomeprazole—Vomiting—Eplerenone—coronary artery disease	3.15e-05	0.000176	CcSEcCtD
Esomeprazole—Feeling abnormal—Furosemide—coronary artery disease	3.15e-05	0.000176	CcSEcCtD
Esomeprazole—Leukopenia—Lisinopril—coronary artery disease	3.15e-05	0.000176	CcSEcCtD
Esomeprazole—Nausea—Fenofibrate—coronary artery disease	3.14e-05	0.000176	CcSEcCtD
Esomeprazole—Pruritus—Niacin—coronary artery disease	3.14e-05	0.000176	CcSEcCtD
Esomeprazole—Asthenia—Pravastatin—coronary artery disease	3.13e-05	0.000175	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Furosemide—coronary artery disease	3.13e-05	0.000175	CcSEcCtD
Esomeprazole—Rash—Eplerenone—coronary artery disease	3.13e-05	0.000175	CcSEcCtD
Esomeprazole—Urticaria—Perindopril—coronary artery disease	3.13e-05	0.000175	CcSEcCtD
Esomeprazole—Hypersensitivity—Trandolapril—coronary artery disease	3.13e-05	0.000175	CcSEcCtD
Esomeprazole—Dermatitis—Eplerenone—coronary artery disease	3.12e-05	0.000175	CcSEcCtD
Esomeprazole—Diarrhoea—Valsartan—coronary artery disease	3.12e-05	0.000175	CcSEcCtD
Esomeprazole—Confusional state—Timolol—coronary artery disease	3.12e-05	0.000175	CcSEcCtD
Esomeprazole—Shock—Ramipril—coronary artery disease	3.11e-05	0.000174	CcSEcCtD
Esomeprazole—Hypersensitivity—Enalapril—coronary artery disease	3.11e-05	0.000174	CcSEcCtD
Esomeprazole—Abdominal pain—Perindopril—coronary artery disease	3.11e-05	0.000174	CcSEcCtD
Esomeprazole—Body temperature increased—Perindopril—coronary artery disease	3.11e-05	0.000174	CcSEcCtD
Esomeprazole—Palpitations—Lisinopril—coronary artery disease	3.11e-05	0.000174	CcSEcCtD
Esomeprazole—Diarrhoea—Olmesartan—coronary artery disease	3.11e-05	0.000174	CcSEcCtD
Esomeprazole—Headache—Eplerenone—coronary artery disease	3.11e-05	0.000174	CcSEcCtD
Esomeprazole—Nervous system disorder—Ramipril—coronary artery disease	3.1e-05	0.000174	CcSEcCtD
Esomeprazole—Thrombocytopenia—Ramipril—coronary artery disease	3.1e-05	0.000173	CcSEcCtD
Esomeprazole—Anaphylactic shock—Timolol—coronary artery disease	3.09e-05	0.000173	CcSEcCtD
Esomeprazole—Pruritus—Pravastatin—coronary artery disease	3.09e-05	0.000173	CcSEcCtD
Esomeprazole—Nausea—Clopidogrel—coronary artery disease	3.09e-05	0.000173	CcSEcCtD
Esomeprazole—Tachycardia—Ramipril—coronary artery disease	3.09e-05	0.000173	CcSEcCtD
Esomeprazole—Skin disorder—Ramipril—coronary artery disease	3.07e-05	0.000172	CcSEcCtD
Esomeprazole—Infection—Timolol—coronary artery disease	3.07e-05	0.000172	CcSEcCtD
Esomeprazole—Vomiting—Simvastatin—coronary artery disease	3.07e-05	0.000172	CcSEcCtD
Esomeprazole—Hypersensitivity—Telmisartan—coronary artery disease	3.07e-05	0.000172	CcSEcCtD
Esomeprazole—Cough—Lisinopril—coronary artery disease	3.07e-05	0.000172	CcSEcCtD
Esomeprazole—Nausea—Lovastatin—coronary artery disease	3.07e-05	0.000172	CcSEcCtD
Esomeprazole—Hyperhidrosis—Ramipril—coronary artery disease	3.06e-05	0.000171	CcSEcCtD
Esomeprazole—Rash—Simvastatin—coronary artery disease	3.05e-05	0.00017	CcSEcCtD
Esomeprazole—Dermatitis—Simvastatin—coronary artery disease	3.04e-05	0.00017	CcSEcCtD
Esomeprazole—Asthenia—Trandolapril—coronary artery disease	3.04e-05	0.00017	CcSEcCtD
Esomeprazole—Shock—Timolol—coronary artery disease	3.04e-05	0.00017	CcSEcCtD
Esomeprazole—Feeling abnormal—Losartan—coronary artery disease	3.04e-05	0.00017	CcSEcCtD
Esomeprazole—Urticaria—Furosemide—coronary artery disease	3.04e-05	0.00017	CcSEcCtD
Esomeprazole—Diarrhoea—Niacin—coronary artery disease	3.04e-05	0.00017	CcSEcCtD
Esomeprazole—Nervous system disorder—Timolol—coronary artery disease	3.03e-05	0.00017	CcSEcCtD
Esomeprazole—Asthenia—Enalapril—coronary artery disease	3.03e-05	0.00017	CcSEcCtD
Esomeprazole—Headache—Simvastatin—coronary artery disease	3.03e-05	0.000169	CcSEcCtD
Esomeprazole—Abdominal pain—Furosemide—coronary artery disease	3.02e-05	0.000169	CcSEcCtD
Esomeprazole—Body temperature increased—Furosemide—coronary artery disease	3.02e-05	0.000169	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Losartan—coronary artery disease	3.02e-05	0.000169	CcSEcCtD
Esomeprazole—Dizziness—Valsartan—coronary artery disease	3.02e-05	0.000169	CcSEcCtD
Esomeprazole—Anorexia—Ramipril—coronary artery disease	3.02e-05	0.000169	CcSEcCtD
Esomeprazole—Nausea—Ezetimibe—coronary artery disease	3.01e-05	0.000168	CcSEcCtD
Esomeprazole—Skin disorder—Timolol—coronary artery disease	3e-05	0.000168	CcSEcCtD
Esomeprazole—Dizziness—Olmesartan—coronary artery disease	3e-05	0.000168	CcSEcCtD
Esomeprazole—Pruritus—Trandolapril—coronary artery disease	3e-05	0.000168	CcSEcCtD
Esomeprazole—Chest pain—Lisinopril—coronary artery disease	2.99e-05	0.000168	CcSEcCtD
Esomeprazole—Arthralgia—Lisinopril—coronary artery disease	2.99e-05	0.000168	CcSEcCtD
Esomeprazole—Myalgia—Lisinopril—coronary artery disease	2.99e-05	0.000168	CcSEcCtD
Esomeprazole—Hyperhidrosis—Timolol—coronary artery disease	2.99e-05	0.000167	CcSEcCtD
Esomeprazole—Asthenia—Telmisartan—coronary artery disease	2.99e-05	0.000167	CcSEcCtD
Esomeprazole—Pruritus—Enalapril—coronary artery disease	2.99e-05	0.000167	CcSEcCtD
Esomeprazole—Diarrhoea—Pravastatin—coronary artery disease	2.99e-05	0.000167	CcSEcCtD
Esomeprazole—Anxiety—Lisinopril—coronary artery disease	2.98e-05	0.000167	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.97e-05	0.000166	CcSEcCtD
Esomeprazole—Discomfort—Lisinopril—coronary artery disease	2.96e-05	0.000165	CcSEcCtD
Esomeprazole—Anorexia—Timolol—coronary artery disease	2.95e-05	0.000165	CcSEcCtD
Esomeprazole—Pruritus—Telmisartan—coronary artery disease	2.95e-05	0.000165	CcSEcCtD
Esomeprazole—Nausea—Eplerenone—coronary artery disease	2.95e-05	0.000165	CcSEcCtD
Esomeprazole—Dizziness—Niacin—coronary artery disease	2.93e-05	0.000164	CcSEcCtD
Esomeprazole—Urticaria—Losartan—coronary artery disease	2.93e-05	0.000164	CcSEcCtD
Esomeprazole—Dry mouth—Lisinopril—coronary artery disease	2.93e-05	0.000164	CcSEcCtD
Esomeprazole—Abdominal pain—Losartan—coronary artery disease	2.92e-05	0.000163	CcSEcCtD
Esomeprazole—Body temperature increased—Losartan—coronary artery disease	2.92e-05	0.000163	CcSEcCtD
Esomeprazole—Asthenia—Captopril—coronary artery disease	2.91e-05	0.000163	CcSEcCtD
Esomeprazole—Diarrhoea—Trandolapril—coronary artery disease	2.9e-05	0.000162	CcSEcCtD
Esomeprazole—Vomiting—Valsartan—coronary artery disease	2.9e-05	0.000162	CcSEcCtD
Esomeprazole—Confusional state—Lisinopril—coronary artery disease	2.89e-05	0.000162	CcSEcCtD
Esomeprazole—Diarrhoea—Enalapril—coronary artery disease	2.89e-05	0.000162	CcSEcCtD
Esomeprazole—Dizziness—Pravastatin—coronary artery disease	2.89e-05	0.000162	CcSEcCtD
Esomeprazole—Vomiting—Olmesartan—coronary artery disease	2.89e-05	0.000162	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.88e-05	0.000161	CcSEcCtD
Esomeprazole—Rash—Valsartan—coronary artery disease	2.88e-05	0.000161	CcSEcCtD
Esomeprazole—Dermatitis—Valsartan—coronary artery disease	2.87e-05	0.000161	CcSEcCtD
Esomeprazole—Nausea—Simvastatin—coronary artery disease	2.87e-05	0.000161	CcSEcCtD
Esomeprazole—Anaphylactic shock—Lisinopril—coronary artery disease	2.87e-05	0.000161	CcSEcCtD
Esomeprazole—Pruritus—Captopril—coronary artery disease	2.87e-05	0.00016	CcSEcCtD
Esomeprazole—Rash—Olmesartan—coronary artery disease	2.86e-05	0.00016	CcSEcCtD
Esomeprazole—Insomnia—Ramipril—coronary artery disease	2.86e-05	0.00016	CcSEcCtD
Esomeprazole—Dermatitis—Olmesartan—coronary artery disease	2.86e-05	0.00016	CcSEcCtD
Esomeprazole—Headache—Valsartan—coronary artery disease	2.86e-05	0.00016	CcSEcCtD
Esomeprazole—Diarrhoea—Telmisartan—coronary artery disease	2.85e-05	0.00016	CcSEcCtD
Esomeprazole—Infection—Lisinopril—coronary artery disease	2.85e-05	0.00016	CcSEcCtD
Esomeprazole—Headache—Olmesartan—coronary artery disease	2.84e-05	0.000159	CcSEcCtD
Esomeprazole—Paraesthesia—Ramipril—coronary artery disease	2.84e-05	0.000159	CcSEcCtD
Esomeprazole—Shock—Lisinopril—coronary artery disease	2.82e-05	0.000158	CcSEcCtD
Esomeprazole—Asthenia—Perindopril—coronary artery disease	2.82e-05	0.000158	CcSEcCtD
Esomeprazole—Dyspnoea—Ramipril—coronary artery disease	2.82e-05	0.000158	CcSEcCtD
Esomeprazole—Vomiting—Niacin—coronary artery disease	2.82e-05	0.000158	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Timolol—coronary artery disease	2.82e-05	0.000158	CcSEcCtD
Esomeprazole—Hypersensitivity—Furosemide—coronary artery disease	2.82e-05	0.000158	CcSEcCtD
Esomeprazole—Somnolence—Ramipril—coronary artery disease	2.81e-05	0.000157	CcSEcCtD
Esomeprazole—Thrombocytopenia—Lisinopril—coronary artery disease	2.81e-05	0.000157	CcSEcCtD
Esomeprazole—Dizziness—Trandolapril—coronary artery disease	2.8e-05	0.000157	CcSEcCtD
Esomeprazole—Tachycardia—Lisinopril—coronary artery disease	2.8e-05	0.000157	CcSEcCtD
Esomeprazole—Insomnia—Timolol—coronary artery disease	2.8e-05	0.000157	CcSEcCtD
Esomeprazole—Rash—Niacin—coronary artery disease	2.8e-05	0.000157	CcSEcCtD
Esomeprazole—Dermatitis—Niacin—coronary artery disease	2.79e-05	0.000156	CcSEcCtD
Esomeprazole—Dizziness—Enalapril—coronary artery disease	2.79e-05	0.000156	CcSEcCtD
Esomeprazole—Skin disorder—Lisinopril—coronary artery disease	2.79e-05	0.000156	CcSEcCtD
Esomeprazole—Dyspepsia—Ramipril—coronary artery disease	2.79e-05	0.000156	CcSEcCtD
Esomeprazole—Pruritus—Perindopril—coronary artery disease	2.78e-05	0.000156	CcSEcCtD
Esomeprazole—Headache—Niacin—coronary artery disease	2.78e-05	0.000156	CcSEcCtD
Esomeprazole—Paraesthesia—Timolol—coronary artery disease	2.78e-05	0.000155	CcSEcCtD
Esomeprazole—Vomiting—Pravastatin—coronary artery disease	2.78e-05	0.000155	CcSEcCtD
Esomeprazole—Hyperhidrosis—Lisinopril—coronary artery disease	2.77e-05	0.000155	CcSEcCtD
Esomeprazole—Diarrhoea—Captopril—coronary artery disease	2.77e-05	0.000155	CcSEcCtD
Esomeprazole—Dyspnoea—Timolol—coronary artery disease	2.76e-05	0.000154	CcSEcCtD
Esomeprazole—Dizziness—Telmisartan—coronary artery disease	2.76e-05	0.000154	CcSEcCtD
Esomeprazole—Rash—Pravastatin—coronary artery disease	2.75e-05	0.000154	CcSEcCtD
Esomeprazole—Dermatitis—Pravastatin—coronary artery disease	2.75e-05	0.000154	CcSEcCtD
Esomeprazole—Decreased appetite—Ramipril—coronary artery disease	2.75e-05	0.000154	CcSEcCtD
Esomeprazole—Somnolence—Timolol—coronary artery disease	2.75e-05	0.000154	CcSEcCtD
Esomeprazole—Asthenia—Furosemide—coronary artery disease	2.74e-05	0.000154	CcSEcCtD
Esomeprazole—Headache—Pravastatin—coronary artery disease	2.74e-05	0.000153	CcSEcCtD
Esomeprazole—Anorexia—Lisinopril—coronary artery disease	2.74e-05	0.000153	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Ramipril—coronary artery disease	2.73e-05	0.000153	CcSEcCtD
Esomeprazole—Fatigue—Ramipril—coronary artery disease	2.73e-05	0.000153	CcSEcCtD
Esomeprazole—Dyspepsia—Timolol—coronary artery disease	2.72e-05	0.000152	CcSEcCtD
Esomeprazole—Hypersensitivity—Losartan—coronary artery disease	2.72e-05	0.000152	CcSEcCtD
Esomeprazole—Nausea—Valsartan—coronary artery disease	2.71e-05	0.000152	CcSEcCtD
Esomeprazole—Pruritus—Furosemide—coronary artery disease	2.71e-05	0.000151	CcSEcCtD
Esomeprazole—Constipation—Ramipril—coronary artery disease	2.71e-05	0.000151	CcSEcCtD
Esomeprazole—Nausea—Olmesartan—coronary artery disease	2.7e-05	0.000151	CcSEcCtD
Esomeprazole—Vomiting—Trandolapril—coronary artery disease	2.7e-05	0.000151	CcSEcCtD
Esomeprazole—Diarrhoea—Perindopril—coronary artery disease	2.69e-05	0.000151	CcSEcCtD
Esomeprazole—Decreased appetite—Timolol—coronary artery disease	2.69e-05	0.00015	CcSEcCtD
Esomeprazole—Vomiting—Enalapril—coronary artery disease	2.69e-05	0.00015	CcSEcCtD
Esomeprazole—Dizziness—Captopril—coronary artery disease	2.68e-05	0.00015	CcSEcCtD
Esomeprazole—Rash—Trandolapril—coronary artery disease	2.67e-05	0.00015	CcSEcCtD
Esomeprazole—Dermatitis—Trandolapril—coronary artery disease	2.67e-05	0.00015	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Timolol—coronary artery disease	2.67e-05	0.000149	CcSEcCtD
Esomeprazole—Fatigue—Timolol—coronary artery disease	2.67e-05	0.000149	CcSEcCtD
Esomeprazole—Rash—Enalapril—coronary artery disease	2.66e-05	0.000149	CcSEcCtD
Esomeprazole—Dermatitis—Enalapril—coronary artery disease	2.66e-05	0.000149	CcSEcCtD
Esomeprazole—Headache—Trandolapril—coronary artery disease	2.66e-05	0.000149	CcSEcCtD
Esomeprazole—Vomiting—Telmisartan—coronary artery disease	2.65e-05	0.000148	CcSEcCtD
Esomeprazole—Asthenia—Losartan—coronary artery disease	2.65e-05	0.000148	CcSEcCtD
Esomeprazole—Headache—Enalapril—coronary artery disease	2.65e-05	0.000148	CcSEcCtD
Esomeprazole—Pain—Timolol—coronary artery disease	2.65e-05	0.000148	CcSEcCtD
Esomeprazole—Nausea—Niacin—coronary artery disease	2.64e-05	0.000147	CcSEcCtD
Esomeprazole—Rash—Telmisartan—coronary artery disease	2.63e-05	0.000147	CcSEcCtD
Esomeprazole—Dermatitis—Telmisartan—coronary artery disease	2.62e-05	0.000147	CcSEcCtD
Esomeprazole—Diarrhoea—Furosemide—coronary artery disease	2.62e-05	0.000146	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.61e-05	0.000146	CcSEcCtD
Esomeprazole—Pruritus—Losartan—coronary artery disease	2.61e-05	0.000146	CcSEcCtD
Esomeprazole—Headache—Telmisartan—coronary artery disease	2.61e-05	0.000146	CcSEcCtD
Esomeprazole—Feeling abnormal—Ramipril—coronary artery disease	2.61e-05	0.000146	CcSEcCtD
Esomeprazole—Dizziness—Perindopril—coronary artery disease	2.6e-05	0.000146	CcSEcCtD
Esomeprazole—Insomnia—Lisinopril—coronary artery disease	2.6e-05	0.000145	CcSEcCtD
Esomeprazole—Nausea—Pravastatin—coronary artery disease	2.59e-05	0.000145	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Ramipril—coronary artery disease	2.59e-05	0.000145	CcSEcCtD
Esomeprazole—Paraesthesia—Lisinopril—coronary artery disease	2.58e-05	0.000144	CcSEcCtD
Esomeprazole—Vomiting—Captopril—coronary artery disease	2.58e-05	0.000144	CcSEcCtD
Esomeprazole—Dyspnoea—Lisinopril—coronary artery disease	2.56e-05	0.000143	CcSEcCtD
Esomeprazole—Rash—Captopril—coronary artery disease	2.55e-05	0.000143	CcSEcCtD
Esomeprazole—Dermatitis—Captopril—coronary artery disease	2.55e-05	0.000143	CcSEcCtD
Esomeprazole—Somnolence—Lisinopril—coronary artery disease	2.55e-05	0.000143	CcSEcCtD
Esomeprazole—Feeling abnormal—Timolol—coronary artery disease	2.55e-05	0.000143	CcSEcCtD
Esomeprazole—Headache—Captopril—coronary artery disease	2.54e-05	0.000142	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Timolol—coronary artery disease	2.53e-05	0.000142	CcSEcCtD
Esomeprazole—Dizziness—Furosemide—coronary artery disease	2.53e-05	0.000142	CcSEcCtD
Esomeprazole—Dyspepsia—Lisinopril—coronary artery disease	2.53e-05	0.000141	CcSEcCtD
Esomeprazole—Diarrhoea—Losartan—coronary artery disease	2.52e-05	0.000141	CcSEcCtD
Esomeprazole—Nausea—Trandolapril—coronary artery disease	2.52e-05	0.000141	CcSEcCtD
Esomeprazole—Urticaria—Ramipril—coronary artery disease	2.51e-05	0.000141	CcSEcCtD
Esomeprazole—Nausea—Enalapril—coronary artery disease	2.51e-05	0.00014	CcSEcCtD
Esomeprazole—Vomiting—Perindopril—coronary artery disease	2.5e-05	0.00014	CcSEcCtD
Esomeprazole—Abdominal pain—Ramipril—coronary artery disease	2.5e-05	0.00014	CcSEcCtD
Esomeprazole—Body temperature increased—Ramipril—coronary artery disease	2.5e-05	0.00014	CcSEcCtD
Esomeprazole—Decreased appetite—Lisinopril—coronary artery disease	2.49e-05	0.00014	CcSEcCtD
Esomeprazole—Rash—Perindopril—coronary artery disease	2.48e-05	0.000139	CcSEcCtD
Esomeprazole—Dermatitis—Perindopril—coronary artery disease	2.48e-05	0.000139	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.48e-05	0.000139	CcSEcCtD
Esomeprazole—Nausea—Telmisartan—coronary artery disease	2.48e-05	0.000139	CcSEcCtD
Esomeprazole—Fatigue—Lisinopril—coronary artery disease	2.47e-05	0.000138	CcSEcCtD
Esomeprazole—Headache—Perindopril—coronary artery disease	2.46e-05	0.000138	CcSEcCtD
Esomeprazole—Urticaria—Timolol—coronary artery disease	2.46e-05	0.000138	CcSEcCtD
Esomeprazole—Constipation—Lisinopril—coronary artery disease	2.45e-05	0.000137	CcSEcCtD
Esomeprazole—Pain—Lisinopril—coronary artery disease	2.45e-05	0.000137	CcSEcCtD
Esomeprazole—Body temperature increased—Timolol—coronary artery disease	2.45e-05	0.000137	CcSEcCtD
Esomeprazole—Abdominal pain—Timolol—coronary artery disease	2.45e-05	0.000137	CcSEcCtD
Esomeprazole—Dizziness—Losartan—coronary artery disease	2.44e-05	0.000137	CcSEcCtD
Esomeprazole—Vomiting—Furosemide—coronary artery disease	2.43e-05	0.000136	CcSEcCtD
Esomeprazole—Rash—Furosemide—coronary artery disease	2.41e-05	0.000135	CcSEcCtD
Esomeprazole—Dermatitis—Furosemide—coronary artery disease	2.41e-05	0.000135	CcSEcCtD
Esomeprazole—Nausea—Captopril—coronary artery disease	2.41e-05	0.000135	CcSEcCtD
Esomeprazole—Headache—Furosemide—coronary artery disease	2.4e-05	0.000134	CcSEcCtD
Esomeprazole—Feeling abnormal—Lisinopril—coronary artery disease	2.36e-05	0.000132	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Lisinopril—coronary artery disease	2.35e-05	0.000131	CcSEcCtD
Esomeprazole—Vomiting—Losartan—coronary artery disease	2.35e-05	0.000131	CcSEcCtD
Esomeprazole—Nausea—Perindopril—coronary artery disease	2.34e-05	0.000131	CcSEcCtD
Esomeprazole—Hypersensitivity—Ramipril—coronary artery disease	2.33e-05	0.00013	CcSEcCtD
Esomeprazole—Rash—Losartan—coronary artery disease	2.33e-05	0.00013	CcSEcCtD
Esomeprazole—Dermatitis—Losartan—coronary artery disease	2.32e-05	0.00013	CcSEcCtD
Esomeprazole—Headache—Losartan—coronary artery disease	2.31e-05	0.000129	CcSEcCtD
Esomeprazole—Urticaria—Lisinopril—coronary artery disease	2.28e-05	0.000128	CcSEcCtD
Esomeprazole—Hypersensitivity—Timolol—coronary artery disease	2.28e-05	0.000128	CcSEcCtD
Esomeprazole—Nausea—Furosemide—coronary artery disease	2.27e-05	0.000127	CcSEcCtD
Esomeprazole—Asthenia—Ramipril—coronary artery disease	2.27e-05	0.000127	CcSEcCtD
Esomeprazole—Body temperature increased—Lisinopril—coronary artery disease	2.27e-05	0.000127	CcSEcCtD
Esomeprazole—Abdominal pain—Lisinopril—coronary artery disease	2.27e-05	0.000127	CcSEcCtD
Esomeprazole—Pruritus—Ramipril—coronary artery disease	2.24e-05	0.000125	CcSEcCtD
Esomeprazole—Asthenia—Timolol—coronary artery disease	2.22e-05	0.000124	CcSEcCtD
Esomeprazole—Nausea—Losartan—coronary artery disease	2.19e-05	0.000123	CcSEcCtD
Esomeprazole—Pruritus—Timolol—coronary artery disease	2.19e-05	0.000122	CcSEcCtD
Esomeprazole—Diarrhoea—Ramipril—coronary artery disease	2.16e-05	0.000121	CcSEcCtD
Esomeprazole—Diarrhoea—Timolol—coronary artery disease	2.12e-05	0.000118	CcSEcCtD
Esomeprazole—Hypersensitivity—Lisinopril—coronary artery disease	2.11e-05	0.000118	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—CKMT1B—coronary artery disease	2.1e-05	0.000409	CbGpPWpGaD
Esomeprazole—Dizziness—Ramipril—coronary artery disease	2.09e-05	0.000117	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—GCLC—coronary artery disease	2.09e-05	0.000408	CbGpPWpGaD
Esomeprazole—Asthenia—Lisinopril—coronary artery disease	2.06e-05	0.000115	CcSEcCtD
Esomeprazole—Dizziness—Timolol—coronary artery disease	2.05e-05	0.000114	CcSEcCtD
Esomeprazole—Pruritus—Lisinopril—coronary artery disease	2.03e-05	0.000114	CcSEcCtD
Esomeprazole—Vomiting—Ramipril—coronary artery disease	2.01e-05	0.000113	CcSEcCtD
Esomeprazole—Rash—Ramipril—coronary artery disease	2e-05	0.000112	CcSEcCtD
Esomeprazole—Dermatitis—Ramipril—coronary artery disease	1.99e-05	0.000112	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—TXNRD1—coronary artery disease	1.98e-05	0.000387	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP11B2—coronary artery disease	1.98e-05	0.000387	CbGpPWpGaD
Esomeprazole—Headache—Ramipril—coronary artery disease	1.98e-05	0.000111	CcSEcCtD
Esomeprazole—Vomiting—Timolol—coronary artery disease	1.97e-05	0.00011	CcSEcCtD
Esomeprazole—Diarrhoea—Lisinopril—coronary artery disease	1.96e-05	0.00011	CcSEcCtD
Esomeprazole—Rash—Timolol—coronary artery disease	1.95e-05	0.000109	CcSEcCtD
Esomeprazole—Dermatitis—Timolol—coronary artery disease	1.95e-05	0.000109	CcSEcCtD
Esomeprazole—Headache—Timolol—coronary artery disease	1.94e-05	0.000108	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ARNTL—coronary artery disease	1.93e-05	0.000376	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—HADH—coronary artery disease	1.93e-05	0.000376	CbGpPWpGaD
Esomeprazole—Dizziness—Lisinopril—coronary artery disease	1.9e-05	0.000106	CcSEcCtD
Esomeprazole—Nausea—Ramipril—coronary artery disease	1.88e-05	0.000105	CcSEcCtD
Esomeprazole—Nausea—Timolol—coronary artery disease	1.84e-05	0.000103	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOA2—coronary artery disease	1.83e-05	0.000356	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX2—coronary artery disease	1.83e-05	0.000356	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G2A—coronary artery disease	1.83e-05	0.000356	CbGpPWpGaD
Esomeprazole—Vomiting—Lisinopril—coronary artery disease	1.82e-05	0.000102	CcSEcCtD
Esomeprazole—Rash—Lisinopril—coronary artery disease	1.81e-05	0.000101	CcSEcCtD
Esomeprazole—Dermatitis—Lisinopril—coronary artery disease	1.81e-05	0.000101	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ABCG5—coronary artery disease	1.8e-05	0.000352	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—coronary artery disease	1.8e-05	0.000352	CbGpPWpGaD
Esomeprazole—Headache—Lisinopril—coronary artery disease	1.8e-05	0.000101	CcSEcCtD
Esomeprazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—coronary artery disease	1.79e-05	0.00035	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—HADHA—coronary artery disease	1.78e-05	0.000347	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LPA—coronary artery disease	1.74e-05	0.00034	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CKM—coronary artery disease	1.71e-05	0.000333	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPAP2B—coronary artery disease	1.71e-05	0.000333	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—UQCRFS1—coronary artery disease	1.71e-05	0.000333	CbGpPWpGaD
Esomeprazole—Nausea—Lisinopril—coronary artery disease	1.7e-05	9.54e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOA5—coronary artery disease	1.67e-05	0.000326	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—coronary artery disease	1.64e-05	0.000319	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—GGT1—coronary artery disease	1.63e-05	0.000318	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G1B—coronary artery disease	1.61e-05	0.000313	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CKMT2—coronary artery disease	1.59e-05	0.00031	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SULT4A1—coronary artery disease	1.59e-05	0.00031	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALDH6A1—coronary artery disease	1.59e-05	0.00031	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PYGM—coronary artery disease	1.59e-05	0.00031	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PDK4—coronary artery disease	1.59e-05	0.00031	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—POMC—coronary artery disease	1.58e-05	0.000309	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CA5B—coronary artery disease	1.48e-05	0.000289	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—GSTP1—coronary artery disease	1.47e-05	0.000286	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—GSTP1—coronary artery disease	1.45e-05	0.000282	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PFKM—coronary artery disease	1.42e-05	0.000276	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LDHA—coronary artery disease	1.42e-05	0.000276	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HMGCS2—coronary artery disease	1.42e-05	0.000276	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GYG1—coronary artery disease	1.42e-05	0.000276	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GK—coronary artery disease	1.42e-05	0.000276	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GATM—coronary artery disease	1.42e-05	0.000276	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—coronary artery disease	1.38e-05	0.00027	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—coronary artery disease	1.38e-05	0.00027	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—coronary artery disease	1.38e-05	0.000268	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LDLR—coronary artery disease	1.37e-05	0.000267	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GCH1—coronary artery disease	1.35e-05	0.000263	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AK1—coronary artery disease	1.35e-05	0.000263	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—GSTM1—coronary artery disease	1.35e-05	0.000263	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CETP—coronary artery disease	1.34e-05	0.00026	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—GSTM1—coronary artery disease	1.33e-05	0.000259	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	1.32e-05	0.000257	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPAT—coronary artery disease	1.3e-05	0.000252	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—MDH2—coronary artery disease	1.3e-05	0.000252	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—UGCG—coronary artery disease	1.3e-05	0.000252	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PLCD1—coronary artery disease	1.3e-05	0.000252	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CKMT1B—coronary artery disease	1.26e-05	0.000246	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PGM1—coronary artery disease	1.25e-05	0.000243	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	1.22e-05	0.000238	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	1.21e-05	0.000235	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PYGB—coronary artery disease	1.2e-05	0.000235	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CKB—coronary artery disease	1.2e-05	0.000235	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—COX5B—coronary artery disease	1.13e-05	0.000221	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PFKFB3—coronary artery disease	1.13e-05	0.000221	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PLIN1—coronary artery disease	1.13e-05	0.000221	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—DLAT—coronary artery disease	1.13e-05	0.000221	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTM2—coronary artery disease	1.13e-05	0.000221	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	1.08e-05	0.00021	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SULT1E1—coronary artery disease	1.07e-05	0.000209	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	1.04e-05	0.000203	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPAP2B—coronary artery disease	1.03e-05	0.0002	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	1.03e-05	0.0002	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CKM—coronary artery disease	1.03e-05	0.0002	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AKR1B1—coronary artery disease	1.02e-05	0.0002	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HK2—coronary artery disease	1.02e-05	0.0002	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC27A1—coronary artery disease	9.82e-06	0.000191	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LCAT—coronary artery disease	9.63e-06	0.000188	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CPT1B—coronary artery disease	9.63e-06	0.000188	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PDK4—coronary artery disease	9.56e-06	0.000186	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CKMT2—coronary artery disease	9.56e-06	0.000186	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SULT4A1—coronary artery disease	9.56e-06	0.000186	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PYGM—coronary artery disease	9.56e-06	0.000186	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	9.56e-06	0.000186	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—POMC—coronary artery disease	9.53e-06	0.000186	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOA4—coronary artery disease	9.45e-06	0.000184	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	9.28e-06	0.000181	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PDHA1—coronary artery disease	9.13e-06	0.000178	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GCLM—coronary artery disease	9.13e-06	0.000178	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	8.85e-06	0.000172	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP11B2—coronary artery disease	8.84e-06	0.000172	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—TXNRD1—coronary artery disease	8.84e-06	0.000172	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC22A3—coronary artery disease	8.71e-06	0.00017	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HADH—coronary artery disease	8.58e-06	0.000167	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ARNTL—coronary artery disease	8.58e-06	0.000167	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PFKM—coronary artery disease	8.52e-06	0.000166	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GK—coronary artery disease	8.52e-06	0.000166	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HMGCS2—coronary artery disease	8.52e-06	0.000166	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LDHA—coronary artery disease	8.52e-06	0.000166	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GYG1—coronary artery disease	8.52e-06	0.000166	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GATM—coronary artery disease	8.52e-06	0.000166	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	8.45e-06	0.000165	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	8.24e-06	0.000161	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PLA2G2A—coronary artery disease	8.14e-06	0.000159	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GPX2—coronary artery disease	8.14e-06	0.000159	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOA2—coronary artery disease	8.14e-06	0.000159	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AK1—coronary artery disease	8.13e-06	0.000158	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GCH1—coronary artery disease	8.13e-06	0.000158	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SULT1A1—coronary artery disease	8.04e-06	0.000157	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ABCG5—coronary artery disease	8.04e-06	0.000157	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GPX4—coronary artery disease	8.04e-06	0.000157	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HK1—coronary artery disease	8.04e-06	0.000157	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	8.03e-06	0.000156	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HADHA—coronary artery disease	7.94e-06	0.000155	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTA1—coronary artery disease	7.85e-06	0.000153	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—MDH2—coronary artery disease	7.79e-06	0.000152	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—UGCG—coronary artery disease	7.79e-06	0.000152	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PLCD1—coronary artery disease	7.79e-06	0.000152	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPAT—coronary artery disease	7.79e-06	0.000152	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LPA—coronary artery disease	7.76e-06	0.000151	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PLCB3—coronary artery disease	7.52e-06	0.000146	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PGM1—coronary artery disease	7.5e-06	0.000146	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOA5—coronary artery disease	7.44e-06	0.000145	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—P4HB—coronary artery disease	7.3e-06	0.000142	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PYGB—coronary artery disease	7.24e-06	0.000141	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CKB—coronary artery disease	7.24e-06	0.000141	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	7.23e-06	0.000141	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PLA2G1B—coronary artery disease	7.16e-06	0.00014	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	7.08e-06	0.000138	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	7e-06	0.000136	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PFKFB3—coronary artery disease	6.81e-06	0.000133	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—COX5B—coronary artery disease	6.81e-06	0.000133	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PLIN1—coronary artery disease	6.81e-06	0.000133	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—DLAT—coronary artery disease	6.81e-06	0.000133	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTM2—coronary artery disease	6.81e-06	0.000133	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—VCAN—coronary artery disease	6.75e-06	0.000132	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALDOA—coronary artery disease	6.7e-06	0.000131	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—DCN—coronary artery disease	6.5e-06	0.000127	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SULT1E1—coronary artery disease	6.46e-06	0.000126	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALDH2—coronary artery disease	6.33e-06	0.000123	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	6.17e-06	0.00012	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PIK3C2A—coronary artery disease	6.17e-06	0.00012	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LIPC—coronary artery disease	6.17e-06	0.00012	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HBA1—coronary artery disease	6.17e-06	0.00012	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HK2—coronary artery disease	6.16e-06	0.00012	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AKR1B1—coronary artery disease	6.16e-06	0.00012	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOC3—coronary artery disease	6.13e-06	0.000119	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LDLR—coronary artery disease	6.09e-06	0.000119	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	6.08e-06	0.000119	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTT1—coronary artery disease	6.02e-06	0.000117	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC9A1—coronary artery disease	6.02e-06	0.000117	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CETP—coronary artery disease	5.95e-06	0.000116	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GCLC—coronary artery disease	5.95e-06	0.000116	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC27A1—coronary artery disease	5.9e-06	0.000115	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SDC1—coronary artery disease	5.88e-06	0.000115	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LCAT—coronary artery disease	5.79e-06	0.000113	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CPT1B—coronary artery disease	5.79e-06	0.000113	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOA4—coronary artery disease	5.68e-06	0.000111	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PSMB5—coronary artery disease	5.56e-06	0.000108	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PSMA6—coronary artery disease	5.56e-06	0.000108	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.55e-06	0.000108	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PDHA1—coronary artery disease	5.49e-06	0.000107	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GCLM—coronary artery disease	5.49e-06	0.000107	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CTGF—coronary artery disease	5.43e-06	0.000106	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HMGCR—coronary artery disease	5.38e-06	0.000105	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GOT2—coronary artery disease	5.38e-06	0.000105	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—TXNRD1—coronary artery disease	5.32e-06	0.000104	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP11B2—coronary artery disease	5.32e-06	0.000104	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC22A3—coronary artery disease	5.24e-06	0.000102	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HADH—coronary artery disease	5.16e-06	0.000101	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ARNTL—coronary artery disease	5.16e-06	0.000101	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PLCB1—coronary artery disease	4.95e-06	9.64e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOA2—coronary artery disease	4.89e-06	9.53e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	4.89e-06	9.53e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GPX2—coronary artery disease	4.89e-06	9.53e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.85e-06	9.46e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ABCG5—coronary artery disease	4.83e-06	9.42e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HK1—coronary artery disease	4.83e-06	9.42e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SULT1A1—coronary artery disease	4.83e-06	9.42e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GPX4—coronary artery disease	4.83e-06	9.42e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ABCA1—coronary artery disease	4.79e-06	9.34e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HADHA—coronary artery disease	4.77e-06	9.31e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTA1—coronary artery disease	4.72e-06	9.2e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LPA—coronary artery disease	4.67e-06	9.1e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GGT1—coronary artery disease	4.64e-06	9.05e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GOT1—coronary artery disease	4.64e-06	9.05e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PLCB3—coronary artery disease	4.52e-06	8.81e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOA5—coronary artery disease	4.47e-06	8.72e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—P4HB—coronary artery disease	4.39e-06	8.55e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	4.31e-06	8.39e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTP1—coronary artery disease	4.17e-06	8.13e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	4.13e-06	8.05e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HMOX1—coronary artery disease	4.11e-06	8.02e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—VCAN—coronary artery disease	4.06e-06	7.91e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CAT—coronary artery disease	4.06e-06	7.91e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALDOA—coronary artery disease	4.03e-06	7.85e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOB—coronary artery disease	3.94e-06	7.68e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—DCN—coronary artery disease	3.91e-06	7.62e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTM1—coronary artery disease	3.83e-06	7.47e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.8e-06	7.41e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LPL—coronary artery disease	3.76e-06	7.33e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.71e-06	7.23e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HBA1—coronary artery disease	3.71e-06	7.23e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LIPC—coronary artery disease	3.71e-06	7.23e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.71e-06	7.23e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOC3—coronary artery disease	3.68e-06	7.18e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GPX1—coronary artery disease	3.67e-06	7.15e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LDLR—coronary artery disease	3.66e-06	7.14e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.62e-06	7.05e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.62e-06	7.05e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CETP—coronary artery disease	3.58e-06	6.97e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GCLC—coronary artery disease	3.58e-06	6.97e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CD36—coronary artery disease	3.57e-06	6.97e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SDC1—coronary artery disease	3.54e-06	6.89e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPP2CA—coronary artery disease	3.53e-06	6.88e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—MTHFR—coronary artery disease	3.39e-06	6.6e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PSMA6—coronary artery disease	3.34e-06	6.51e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PSMB5—coronary artery disease	3.34e-06	6.51e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CTGF—coronary artery disease	3.26e-06	6.36e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GOT2—coronary artery disease	3.23e-06	6.3e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HMGCR—coronary artery disease	3.23e-06	6.3e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AGT—coronary artery disease	3.22e-06	6.27e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOE—coronary artery disease	3.15e-06	6.15e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOA1—coronary artery disease	3.12e-06	6.08e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.99e-06	5.82e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.97e-06	5.8e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.88e-06	5.62e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GGT1—coronary artery disease	2.79e-06	5.44e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GOT1—coronary artery disease	2.79e-06	5.44e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPARG—coronary artery disease	2.75e-06	5.35e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—POMC—coronary artery disease	2.71e-06	5.28e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.51e-06	4.89e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.49e-06	4.84e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.47e-06	4.82e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALB—coronary artery disease	2.47e-06	4.81e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CAT—coronary artery disease	2.44e-06	4.76e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOB—coronary artery disease	2.37e-06	4.62e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NOS3—coronary artery disease	2.36e-06	4.6e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.3e-06	4.49e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LPL—coronary artery disease	2.26e-06	4.41e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GPX1—coronary artery disease	2.21e-06	4.3e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PTGS2—coronary artery disease	2.16e-06	4.21e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CD36—coronary artery disease	2.15e-06	4.19e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.12e-06	4.14e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.04e-06	3.97e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AGT—coronary artery disease	1.94e-06	3.77e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOE—coronary artery disease	1.9e-06	3.7e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOA1—coronary artery disease	1.87e-06	3.65e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPARG—coronary artery disease	1.65e-06	3.22e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—POMC—coronary artery disease	1.63e-06	3.18e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALB—coronary artery disease	1.49e-06	2.89e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NOS3—coronary artery disease	1.42e-06	2.77e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PIK3CA—coronary artery disease	1.33e-06	2.59e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.3e-06	2.53e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AKT1—coronary artery disease	1.09e-06	2.12e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PIK3CA—coronary artery disease	7.99e-07	1.56e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AKT1—coronary artery disease	6.53e-07	1.27e-05	CbGpPWpGaD
